Fosun Health Soft Tissue Tumor Treatment Center mainly targets soft tissue tumors and some bone tumors in the limbs, trunk, retroperitoneum and other locations. Since there are many types of this disease and its incidence is relatively rare, the center emphasizes completing imaging evaluation and specialist discussion before the first biopsy or surgery to avoid inappropriate resection that affects subsequent margin design, limb salvage opportunities, and local control.
Diagnosis and treatment are jointly participated by orthopedics or oncology surgery, imaging, pathology, radiotherapy, medical oncology, interventional and rehabilitation teams. The team will plan needle biopsy, extended resection, repair and reconstruction, and necessary radiotherapy or drug treatment based on the tumor location, size, pathological subtype, grade, and its relationship with neurovascular and bone.
For soft tissue sarcomas of the limbs, treatment should ensure standard resection margins while preserving limbs and functions as much as possible; for retroperitoneal, paraspinal, or recurrent lesions, multiple organ involvement, previous surgeries, and radiation therapy doses need to be evaluated. The center can rely on platforms such as VitalBeam and M6 CyberKnife to develop precise radiotherapy plans for suitable patients before surgery, after surgery, as well as for local recurrence or bone metastasis.
After treatment, the team will carry out rehabilitation focusing on pain, wounds, muscle strength, joint activities, gait and daily living abilities, and arrange local imaging and distant metastasis monitoring such as the lungs based on pathological risks. Serial follow-up can help identify relapses and functional problems early.
Common treatment pathways for bone and soft tissue tumors
1. Soft tissue sarcoma: The recurrence rate after surgery is high, and most cases require surgery followed by radiotherapy. Modern treatment emphasizes completing MRI or CT, standard puncture biopsy and pathological classification before the first treatment, and then planning limb salvage resection, repair and reconstruction, and preoperative or postoperative radiotherapy. Some subtypes also require drug treatment.
2. Bone metastases: Radiotherapy can relieve or improve pain in most patients. For patients with pain, fracture risk, or spinal cord compression, radiotherapy, surgical fixation, bone-modifying drugs, and systemic treatments may be selected based on stability and nerve compression.
3. Spinal and deep soft tissue tumors: Deep lesions are one of the applicable scenarios for precision radiotherapy. The team will evaluate surgery, conventional fractionated radiotherapy, M6 CyberKnife, or other stereotactic treatments based on pathology, surgical margins, neurovascular relationships, and previous treatments.
4. Some benign or borderline tumors: Whether radiotherapy is needed must be carefully decided based on the pathological type, symptoms, growth rate and surgical risks. Radiotherapy cannot be used as a routine choice for all benign tumors.
